Cargando…
培美曲塞在晚期非小细胞肺癌二线及以上治疗中的疗效分析
BACKGROUND AND OBJECTIVE: Pemetrexed is a standard second-line therapy in advanced non-small cell lung cancer (NSCLC). Currently, cytotoxic treatments beyond second-line therapy are not available. This study evaluated the efficacy and safety of pemetrexed as a salvage regimen in heavily pretreated p...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999869/ https://www.ncbi.nlm.nih.gov/pubmed/22429582 http://dx.doi.org/10.3779/j.issn.1009-3419.2012.03.08 |